Smartwatches can collect millions of clinical-trial measurements. Regulators still need one question answered
Wearable devices are moving beyond step counts and wellness tracking to become clinical-trial instruments, but regulatory acceptance will depend on whether sponsors can prove that digital endpoints are accurate, meaningful and reliable across diverse patient populations.